Gilead Sciences Inc Stock
Gilead Sciences Inc Stock
Gilead Sciences Inc gained 0.320% compared to yesterday.
The stock is an absolute favorite of our community with 54 Buy predictions and no Sell predictions.
With a target price of 124 € there is a slightly positive potential of 4.27% for Gilead Sciences Inc compared to the current price of 118.92 €.
So far the community has only identified positive things for Gilead Sciences Inc stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Gilead Sciences Inc in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Gilead Sciences Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Gilead Sciences Inc | 0.320% | -2.162% | -6.010% | 29.694% | 11.809% | 56.757% | 116.709% |
| IQVIA Holdings Inc. | 0.350% | -4.993% | -3.776% | 11.267% | -26.100% | -22.022% | -16.793% |
| Incyte Corp. | -1.180% | 0.639% | 0.171% | 63.448% | -2.731% | 20.506% | 21.941% |
| Vertex Pharmaceuticals Inc. | 0.030% | -2.156% | -12.518% | -12.805% | -4.991% | 25.008% | 107.580% |
Comments
Gilead Sciences (GILD) had its price target raised by Morgan Stanley from $171.00 to $175.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for GILD provided by MarketBeat
Gilead Sciences (GILD) had its price target lowered by Cantor Fitzgerald from $155.00 to $115.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for GILD provided by MarketBeat
Gilead Sciences (GILD) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $180.00 price target on the stock.
Show more
Ratings data for GILD provided by MarketBeat